# The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia

> **NCT02846259** · — · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 2135 (estimated)

## Conditions studied

- Intracranial Aneurysm
- Cerebral Ischemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02846259
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2019-03
- **Final completion:** 2019-12
- **Target enrollment:** 2135 (ESTIMATED)
- **Last updated:** 2016-11-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02846259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02846259, "The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02846259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*